Document Detail


Combination antiretroviral therapy and incidence of AIDS-related malignancies.
MedLine Citation:
PMID:  10430214     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We evaluated recent trends in the incidence of AIDS-related malignancies using Cox proportional hazards analysis in 622 men with well-characterized dates of HIV seroconversion in the San Francisco City Clinic cohort. By the end of 1996, 182 men had been diagnosed with Kaposi's sarcoma (KS), and 45 men had been diagnosed with lymphoma. The incidence of KS dropped from 3.5 to 0 per 100 person-years between 1993 through 1995 and 1996 (p = .07), whereas lymphoma incidence remained stable between these periods (1.4-1.8, p = .2). Combination antiretroviral therapy increased from 13% to 23% in 1993 through 1995 to 49% in 1996 and 79% in 1997. The decline in KS cannot be explained by earlier declines in HIV incidence, and concurrent increases in antiretroviral therapy suggests that control of viral replication may lead to a direct or indirect effect on KS pathogenesis. Failure to see such a trend for AIDS-related lymphoma may reflect inadequate follow-up time after widespread use of therapy or a need to treat earlier in the course of HIV infection to prevent HIV-associated lymphomagenesis.
Authors:
S P Buchbinder; S D Holmberg; S Scheer; G Colfax; P O'Malley; E Vittinghoff
Related Documents :
14687834 - Primary hepatic non-hodgkin's lymphomas: case report and review of the literature.
20141444 - Human immunodeficiency virus-associated anaplastic large cell lymphoma.
25470984 - Risk factors for retrovirus and hepatitis virus infections in accepted blood donors.
24308704 - Role of immunohistochemistry for hepatitis d and hepatitis b virus in hepatitis delta.
11917814 - Nontuberculous mycobacteria in cystic fibrosis.
23481134 - Clinical characteristics, spontaneous clearance and treatment outcome of acute hepatiti...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  21 Suppl 1     ISSN:  1525-4135     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  1999 Aug 
Date Detail:
Created Date:  1999-08-24     Completed Date:  1999-08-24     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S23-6     Citation Subset:  IM; X    
Affiliation:
HIV Research Section, San Francisco Department of Public Health, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
AIDS-Related Opportunistic Infections / epidemiology*
Anti-HIV Agents* / administration & dosage
Central Nervous System Neoplasms / epidemiology
Drug Therapy, Combination
Humans
Incidence
Lymphoma / epidemiology*
Lymphoma, AIDS-Related / epidemiology
Lymphoma, Non-Hodgkin / epidemiology
Male
Prevalence
Grant Support
ID/Acronym/Agency:
R64/CCU912541//PHS HHS
Chemical
Reg. No./Substance:
0/Anti-HIV Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an...
Next Document:  AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy.